IDH2 is a novel diagnostic and prognostic serum biomarker for non‐small‐cell lung cancer

Lung cancer is the most common leading cause of cancer‐related death worldwide. Late diagnosis contributes to a high mortality rate and poor survival of this cancer. In our previous study, we found that IDH2 polymorphism rs11540478 is a risk factor for lung cancer. Here, we examined IDH2 protein exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jiang‐jiang, Li, Ruilei, Wang, Wenxiang, Zhang, Baihua, Song, Xin, Zhang, Chunfang, Gao, Yang, Liao, Qianjin, He, Ya, You, Shuo, Tan, Zheqiong, Luo, Xiangjian, Li, Yueshuo, Tang, Min, Weng, Xinxian, Yi, Wei, Peng, Shifang, Liu, Shaohui, Tan, Ying, Bode, Ann M., Cao, Ya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928355/
https://www.ncbi.nlm.nih.gov/pubmed/29465809
http://dx.doi.org/10.1002/1878-0261.12182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928355/
https://www.ncbi.nlm.nih.gov/pubmed/29465809
http://dx.doi.org/10.1002/1878-0261.12182

Ejemplares similares